Dividend Dispatch — Header
| 💰 |
|
Dividend Dispatch
|
|
Income is everywhere. I find it.
|
|
|
|
Friday, October 09, 2026
·
6 min read
|
|
|
|
Dividend Dispatch — Today's Theme
|
Today's Theme
|
|
Five sections. Five picks. The week's best income ideas in one place.
|
|
We covered 16 names across four issues this week. I screened BDCs on Monday, found mineral royalties on Wednesday, flagged a yield trap in ABR, and spotted a future Dividend King in MDT. Today I'm pulling one winner from each section — the name that earned pick of the week. The S&P 500 touched new records before Thursday's pullback. The VIX is sitting at 15.41. Markets are calm. But one of today's five picks has a coverage gap I need to show you — and another is exactly one raise away from the most exclusive club in dividend investing.
|
|
|
|
Wall Street insider who called the rise of AI three years in advance reveals the next BIG breakthrough:
A radical "light-speed" device is set to make AI 100x faster… launch a new wave of AI winners… and leave the Magnificent Seven in the dust.
Dividend Dispatch — Section 1a
|
|
The High Yield
Pick of the week — 8%+ yields only
|
|
STWDA decade of $0.48 — but the coverage is slipping
|
Starwood Property Trust is a mortgage REIT — a company that lends money against commercial real estate and collects interest. They've been paying $0.48 per share every quarter for over ten consecutive years. That kind of consistency is rare at this yield level.
But I have to be straight with you. STWD's distributable earnings — the cash they actually generate — came in at $0.40 per share last quarter. The quarter before that: $0.39. Both below the $0.48 they paid out. They're writing checks for more than they're earning right now.
That doesn't mean a cut is coming tomorrow. STWD has reserves, and they invested $2.5 billion in Q2 alone, which should boost future earnings. But if distributable earnings stay below $0.48 for two more quarters, this conversation changes. I'm watching it. You should too.
|
|
Yield: 14.7%
|
$10K invested = $1,471/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Aristocrats
Pick of the week — legacy payers
|
|
ABBV53 straight years — and the ex-date is next Thursday
|
AbbVie makes Humira, Skyrizi, Rinvoq, and Botox. They've raised their dividend for 53 consecutive years — counting back through the Abbott Labs legacy before the 2013 spinoff. The current payout is $1.73 per quarter, or $6.92 a year.
I know — 2.6% doesn't look like much. But AbbVie has been growing that payout by about 5.9% annually over five years, and the Humira patent cliff everyone worried about? Skyrizi and Rinvoq are more than replacing the lost revenue. Here's your deadline: ABBV goes ex-dividend next Thursday, October 15. You need to own shares by close on Wednesday the 14th to collect $1.73. That's a $173 check on every 100 shares, and it's been growing for over half a century. The risk is pharma pipeline concentration — if Skyrizi stumbles, the growth story changes.
|
|
Yield: 2.6%
|
$10K invested = $260/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Growth Stars
Pick of the week — fast risers
|
|
AXP16% raise, 22% payout ratio — this one has room to run
|
American Express raised its quarterly dividend from $0.82 to $0.95 this year — a 16% jump. Last year it was a 17% raise. And the payout ratio is just 22%. That means AXP keeps 78 cents of every dollar it earns and still gives you a raise. That's like a pizza where they keep adding slices instead of cutting yours thinner.
At $304 and a 1.25% yield, this is not a high-income stock today. $10,000 gets you $125 a year. But at 16–17% annual raises, that $125 doubles roughly every four to five years. Today was AXP's ex-dividend date — if you owned it going in, you'll see $0.95 per share on November 10. The risk? AXP is a premium consumer credit company. A recession that hits high-end spending would slow their earnings growth. But with a 22% payout ratio, there's a wide cushion before any cut.
|
|
Yield: 1.25%
|
$10K invested = $125/yr
|
Paid: Quarterly
|
|
|
|
|
|
Marc Chaikin Issues the "Strangest" Prediction of His 60-Year Career
Wall Street legend Marc Chaikin has advised billionaires like George Soros, Steve Cohen and D.E. Shaw. He predicted the 2020 Covid Crash... the 2022 bear... and the 2025 tariff sell-off, too. But he's never made a prediction like the one he just issued.
According to Chaikin, a $248T "White Swan" event is about to overturn the AI industry... and the global order, too. It involves a strange new technology called "micro clusters." These miniaturized data centers will render current AI tech obsolete when it comes to major breakthroughs – including models from SpaceX, Google, Anthropic and OpenAI. And they could send shares of one obscure company soaring starting Oct. 20th. Go here for Marc's full prediction and the name and ticker of the stock, for free.
Dividend Dispatch — Section 1b
|
|
The Weird Yield
Pick of the week — income you'd never expect
|
|
KRPThey don't drill. They don't operate. They just collect royalties.
|
Kimbell Royalty Partners owns mineral rights across over 17 million gross acres. They don't drill wells. They don't run rigs. They don't fix equipment when it breaks. They just own the rights to collect a percentage when someone else pulls oil and gas out of the ground. Think of it like owning a toll booth on someone else's highway.
Last quarter's distribution was $0.47 per unit, which puts the forward yield around 12.9%. That means $10,000 invested generates roughly $1,290 a year. But here's the thing — that $0.47 is variable. When oil prices rise, KRP pays more. When they fall, KRP pays less. In 2020, the distribution dropped to as low as $0.13. This is not a fixed-income replacement. It's a royalty play with real commodity risk. I love the business model, but only with money you won't need to rely on quarter to quarter.
|
|
Yield: 12.9%
|
$10K invested = $1,290/yr
|
Paid: Quarterly
|
|
|
|
|
|
Safety & Watchlist
Pick of the week — reliable picks
|
|
Safe Pick
|
|
MDT49 years of raises — one more and it's a Dividend King
|
Medtronic makes pacemakers, insulin pumps, spinal implants, and surgical robots. They've raised their dividend every single year for 49 consecutive years. One more raise — expected around June 2027 — and MDT becomes a Dividend King, joining the exclusive club of roughly 50 companies that have increased their payout for 50+ straight years.
The current dividend is $0.72 per quarter, or $2.88 a year. At $87.79, the yield is 3.3% — that's $328 a year on every $10,000 invested. The risk here isn't the dividend. It's the stock price. MDT has lagged the S&P 500 for years as revenue growth has been slow. But if you're buying for income durability rather than capital gains, a 49-year streak in healthcare — where demand doesn't disappear in recessions — is about as safe as it gets.
|
|
Yield: 3.3%
|
$10K invested = $328/yr
|
Paid: Quarterly
|
|
|
|
|
|
Dividend Dispatch — Main Rest
|
|
The Extra Yield
The week's calendars, screens & numbers
|
|
Don't miss this ex-date next week: AbbVie (ABBV) goes ex-dividend Thursday, October 15 — $1.73 per share. You must own by close on Wednesday the 14th. Procter & Gamble (PG) is also expected to go ex-dividend sometime between October 16–23. I'll confirm the exact date Monday.
|
|
Week by the numbers: 16 names across four issues. Today's five picks — $10,000 in each — generate a combined $3,474 a year in dividend income. That's $289 a month from $50,000 invested. STWD and KRP do the heavy lifting at 14.7% and 12.9%, while ABBV, AXP, and MDT provide the stability.
|
|
Screen I ran this morning: S&P 500 stocks with payout ratios under 30% that have raised at least 10% in each of the last three years. Only seven names survived. AXP was one. Most of the others were tech and financials — names where the dividend is growing fast but still a tiny fraction of earnings.
|
|
Someone asked me: "Should I own all five weekly picks?" No. They serve different jobs. STWD and KRP are income-now — high yield, higher risk. AXP is income-later — low yield today, fast growth. ABBV and MDT are hold-forever names with decades-long streaks. Match them to what you need right now, not what sounds exciting.
|
|
|
|
The Dispatch
|
|
That's the week — STWD for income, ABBV for legacy, AXP for growth, KRP for something you'd never expect, and MDT for the kind of safety that takes 49 years to build. Monday I'll be back with two fresh high-yield names and two for Safety & Watchlist. I've already got my weekend screening list ready. Have a good one — and go check your dividends.
|
|
— Charlie
|
|
|
|